Sechenov School
Home › Pharmacology › Muscarinic Acetylcholine Receptors

Muscarinic Acetylcholine Receptors

Muscarinic acetylcholine receptors

For medical students2 min readUpdated 2026-10-10

Muscarinic acetylcholine receptors (muscarinic receptors) are receptors that exhibit selective sensitivity to muscarine (a toxic alkaloid found in fly agaric mushrooms). They are located on the cell membranes of effector organs and mediate signal transmission from the parasympathetic nervous system.

SensitivitySelectively respond to muscarine rather than nicotine.
M2 receptorsLocated in the heart, decrease heart rate and contractile force.
M3 receptorsIncrease smooth muscle tone in bronchi, GI tract, and urinary bladder.
Nitric oxideStimulation of endothelial receptors triggers NO release and vasodilation.

General Characteristics and M1 Receptors

Muscarinic acetylcholine receptors are predominantly located on the postsynaptic membrane of effector organs innervated by postganglionic parasympathetic fiber terminals. Several main subtypes are distinguished based on their localization and resulting effects.

SubtypeMain LocalizationKey Effect
M1CNS, stomach (ECL cells)Neuronal transmission, stimulation of HCl production
M2Heart, presynaptic membraneCardiac inhibition, suppression of neurotransmitter release
M3 (innervated)Smooth muscle, exocrine glands, eyeMuscle contraction, profuse glandular secretion
M3 (non-innervated)Vascular endotheliumBlood vessel dilation (vasodilation)

M1 receptors are diffusely distributed in cholinergic synapses of the central nervous system (cortex, brainstem, midbrain, and spinal cord), where they mediate neuronal transmission.

Their crucial peripheral function is the regulation of gastric secretion. In the stomach, they are located on enterochromaffin-like (ECL) cells. These receptors are coupled with Gq proteins, and their stimulation increases cytoplasmic calcium ion (Ca²⁺) levels. This triggers a cascade: ECL cells release histamine, which secondarily stimulates gastric parietal cells to actively secrete hydrochloric acid (HCl).

M2 Receptors: Regulation of Cardiac Function

These receptors are traditionally referred to as 'cardiac' receptors. Their primary function is the inhibition of cardiac activity through specific ionic mechanisms. Upon M2 receptor stimulation, potassium channels are activated, leading to an enhanced efflux of K⁺ ions and membrane hyperpolarization. Simultaneously, phosphorylation of calcium channels decreases, reducing Ca²⁺ influx into cardiomyocytes during depolarization.

Effects on cardiac regions:

In addition to the heart, M2 receptors have a presynaptic localization on the membranes of postganglionic parasympathetic nerve terminals. Their excitation triggers a negative feedback mechanism that inhibits the release of the neurotransmitter (acetylcholine) into the synaptic cleft.

M3 Receptors: Smooth Muscle, Glands, and Blood Vessels

Innervated M3 receptors represent the largest group, mediating classical parasympathetic effects. Their molecular mechanism also involves Gq proteins: activation of phospholipase C leads to the production of inositol 1,4,5-trisphosphate, the release of Ca²⁺ ions from the sarcoplasmic reticulum, and an increase in cytoplasmic calcium concentration.

Main targets of M3 receptors:

  1. Eye: Contraction of the circular muscle of the iris (resulting in pupil constriction — miosis) and the ciliary muscle (causing accommodation spasm, adjusting the eye for near vision).
  2. Smooth muscle of internal organs: Tone increases (except for sphincters), and motility is enhanced in the bronchi, stomach, intestines, biliary tract, uterus, and urinary bladder.
  3. Exocrine glands: A generalized increase in secretion is observed (salivary, lacrimal, bronchial, gastric, sweat, nasopharyngeal, and intestinal glands).

A special subtype is the non-innervated M3 receptor. These lack synaptic connections with nerve endings, are localized on vascular endothelial cells, and respond to circulating agonists in the bloodstream. Stimulation of these receptors leads to the synthesis and release of endothelium-derived relaxing factor (nitric oxide, NO). NO diffuses into the smooth muscle cells of the vessel wall, causing them to relax. As a result, vasodilation occurs and arterial blood pressure decreases.

Mnemonic

Easy localization recall: M1 — one stomach (gastric glands), M2 — two atria and ventricles (heart), M3 — many smooth muscles and exocrine glands throughout the body.

Frequently asked questions

What pharmacological effects occur upon selective stimulation of muscarinic receptors by muscarine compared to nicotine?

Selective stimulation of muscarinic receptors by muscarine results in smooth muscle contraction, whereas nicotine specifically binds to N-cholinergic receptors of skeletal striated muscle. Both substances are specific agonists for different types of cholinergic receptors.

CharacteristicMuscarineNicotine
Receptor typeM-receptor (Muscarinic)N-receptor (Nicotinic)
LocalizationSmooth muscleSynapses of skeletal striated muscle
EffectCauses smooth muscle contractionNot specified in sources
Why are vascular M3 receptors called non-innervated?

Because they are located on the vascular endothelium outside of synaptic clefts and do not receive direct nerve impulses. They are activated exclusively by agonist molecules present in the bloodstream.

How are M1 receptors linked to histamine in the stomach?

Stimulation of M1 receptors causes enterochromaffin-like cells to release histamine. This histamine acts as a secondary stimulator, prompting neighboring parietal cells to produce hydrochloric acid.

What happens to the AV node upon M2 receptor excitation?

In the atrioventricular node, conduction velocity slows down and the refractory period lengthens. This manifests as a negative dromotropic effect.

Go deeper

More topics in Pharmacology

Uricosuric AgentsBiological BarriersCatalytic ReceptorsClassification of Adverse Drug ReactionsSpinal Mechanism of Opioid ActionNonsteroidal Anti-Inflammatory DrugsBenzodiazepine HypnoticsProstaglandins Affecting the MyometriumErythropoietin AgentsIndobufenLipoproteinsAntitussivesPharmacology →